H aematopoietic stem cells (HSCs) are currently classified by a combination of specific surface markers and their functional long-term reconstitution capacity towards all blood lineages in transplantation experiments [1] [2] [3] . There is compelling evidence for the existence of stem cells within the bone marrow 4, 5 . Nevertheless, the dynamics and differentiation steps by which stem cells give rise to diverse blood and immune cell types are difficult to characterize [6] [7] [8] [9] [10] [11] . Given that haematopoiesis is one of the most studied models for somatic development in animals, and aberrant haematopoietic differentiation is a major cause for human malignancies 12, 13 , the gap between HSCs and functional blood lineages remains a field of active research for which many models are being proposed 11, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Single-cell RNA sequencing (scRNA-seq) was recently applied to dissect haematopoietic progenitors and other cell populations 20, [24] [25] [26] [27] [28] [29] [30] . The major advantages of this approach include bypassing the need for a priori markers that define progenitor populations, and the sensitivity to detect rare or even transient transcriptional states de novo, provided that sufficient single cells are sampled 31 . Current studies using scRNA-seq have redefined the transcriptional states of myeloid subtypes and other stem and progenitor populations in the bone marrow 15, 16, 20, [32] [33] [34] [35] [36] [37] [38] [39] , suggesting that the differentiation from HSCs is more complex and less sequential than previously appreciated 9, 40 . However, inference of lineage relationships between cell populations in the bone marrow, when relying solely on a snapshot sample of a priori unrelated single cells, remains practically and theoretically challenging.
H aematopoietic stem cells (HSCs) are currently classified by a combination of specific surface markers and their functional long-term reconstitution capacity towards all blood lineages in transplantation experiments [1] [2] [3] . There is compelling evidence for the existence of stem cells within the bone marrow 4, 5 . Nevertheless, the dynamics and differentiation steps by which stem cells give rise to diverse blood and immune cell types are difficult to characterize [6] [7] [8] [9] [10] [11] . Given that haematopoiesis is one of the most studied models for somatic development in animals, and aberrant haematopoietic differentiation is a major cause for human malignancies 12, 13 , the gap between HSCs and functional blood lineages remains a field of active research for which many models are being proposed 11, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Single-cell RNA sequencing (scRNA-seq) was recently applied to dissect haematopoietic progenitors and other cell populations 20, [24] [25] [26] [27] [28] [29] [30] . The major advantages of this approach include bypassing the need for a priori markers that define progenitor populations, and the sensitivity to detect rare or even transient transcriptional states de novo, provided that sufficient single cells are sampled 31 . Current studies using scRNA-seq have redefined the transcriptional states of myeloid subtypes and other stem and progenitor populations in the bone marrow 15, 16, 20, [32] [33] [34] [35] [36] [37] [38] [39] , suggesting that the differentiation from HSCs is more complex and less sequential than previously appreciated 9, 40 . However, inference of lineage relationships between cell populations in the bone marrow, when relying solely on a snapshot sample of a priori unrelated single cells, remains practically and theoretically challenging.
Here we apply a comprehensive multi-tier scRNA-seq approach coupled with index sorting and CRISP-seq 41 perturbation analysis to perform de novo transcriptional characterization of dormant HSC populations and their immediate derivatives in the bone marrow. We find a spectrum of transcriptional states with progressively more relaxed quiescent HSC signature. Nevertheless, single-cell analyses of mice treated with granulocyte-colony stimulating factor (G-CSF) or erythropoietin (Epo) suggest that cytokine stimulation disrupts HSC dormancy non-specifically before expanding either myeloid or erythrocyte progenitor populations, respectively. In transcriptional states that show a weak HSC transcriptional signature, we observe co-expression of early myeloid and lymphoid genes, but no mixing of erythrocyte genes with myeloid or lymphoid genes. Moreover, myeloid and lymphoid progenitor states are defining a non-hierarchical network of possible differentiation trajectories that precede ultimate functional commitment. CRISP-seq analyses of Cebpa, Irf8 and PU.1 show that the loss of either of these transcription factors modifies the spectrum of progenitor transcriptional states. This leads to the accumulation of weakly differentiated states, rather than blocking hierarchically the initiation of transcriptional priming. Interestingly, we observe an apparent gap between the progenitor states that are linked with HSCs and bona fide B-cell progenitors strongly expressing Vpreb1-3, suggesting that the origin of B cell and other lymphoid populations may be distinct. Our data thus suggest an scRNA-based reference map as a generalization of current hierarchical and discrete models of haematopoietic progenitor cell types.
marrow by implementing a multi-tier sampling design ( Fig. 1a and Supplementary Fig. 1a,b) . Because different haematopoietic cells span several orders of magnitude in abundance, we combined broad sampling of single cells with minimal bias and data-driven depletion and enrichment strategies to deeply probe specific populations. Overall, we profiled 80,108 cells in this study using MARSseq to simultaneously capture RNA and key surface markers across several tiers (Supplementary (Fig. 2a) . Bootstrap analysis was used to confirm meta-cell reproducibility and identify large-scale clusters in the data ( Supplementary Fig. 3d,e) .
Using the expression of 15 established lineage markers ( Supplementary Fig. 3f ) we associated 82% of the cells with specific lineage fates ( Supplementary Fig. 3g ), and 18% of the cells were classified as early progenitors (Fig. 2a,b) . Our reference map of haematopoiesis includes B cell (marked by Vpreb1 and Fcrla), innate lymphocyte (ILC, Ccl5), erythrocyte (Hba-a2 and Car1), monocyte (Ly86 and Csf1r), macrophage (C1qb), neutrophil (Gstm1, Fcnb and Ltf), conventional dendritic cells (cDC, Cd74), plasmacytoid (pDC, Siglech), basophil (Prss34), eosinophil (Prg2) and megakaryocyte (Pf4) progenitors. Interestingly, we observed a transcriptional continuum connecting all lineages, with the exception of B-cell progenitors and innate lymphocytes ( Fig. 2c and Supplementary Fig. 3h ). We projected recorded fluorescence-activated cell sorting (FACS) surface marker levels onto our reference map, and performed in silico gating to align the map with known functional classes ( Fig. 2d and Supplementary Fig. 3i,j) . We found multipotent progenitors (MPPs), short-term (ST) and long-term (LT) HSCs 17, 43, 44 to be co-localized with specific transcriptional clusters at the core of the projected map. We inferred variable proliferation intensities across the map by pooling the expression from genes associated with cell cycle (Fig. 2e and Supplementary Table 2 ). Together, the detailed and unbiased profiling of progenitor transcriptional states in the bone marrow with recorded surface markers form a detailed and unbiased reference model for haematopoiesis, which is readily extendible by enrichment and perturbation strategies, as demonstrated in the following sections.
Transcriptional program of quiescent HSC.
To better identify transcriptional states representing stem cells and their immediate transcriptional derivatives, we focused on cells lacking strong expression of differentiation markers ( Supplementary Fig. 4a and Methods). We named this group of cells and the transcriptional state they represent the 'haematopoietic core' . We then enhanced the resolution around the core, by additional sequencing of 2,524 cells further depleted of differentiated contaminants (tier 5: 45 , and recomputed a meta-cell model for a combined core data set (Fig. 3a,b and Supplementary  Fig. 4b,c) . To identify the most transcriptionally naive stem cell state in the map we focused on sorted HSCs (tier 7), which were further purified in silico by excluding cells mapping to meta-cells with initial activation of differentiation markers ( Fig. 3c and Supplementary  Fig. 4d ). We identified Hlf 46, 47 as the only transcription factor linked with highest enrichment in HSCs (more than fivefold higher; P < 1 × 10
, Mann-Whitney test; Supplementary Fig. 4e ). We then searched directly for genes correlated with Hlf expression at single cell resolution (Fig. 3d and Supplementary Table 2) , characterizing a gene module associated with the most naive HSC state (for example, Ly6a/Sca1, Ifitm1) 11, 47 . We note that, unlike Hlf, which is HSC-specific, some of the observed naive HSC genes are reused in more mature fates. For example, Ifitm1, a gene associated with cell quiescence 48 , is strongly co-expressed with Prss34 and other basophil genes, possibly due to the relatively non-proliferative basophil state. Defining developmental relatedness in the data based on transcription profiles must therefore be approached cautiously.
We defined the HSC signature by pooling the single-cell expression of the Hlf-correlated naive HSC gene module (stem-score, Fig. 3e,f) . As expected we found that high-stem-score cells are defined by low proliferation (Fig. 3g and Supplementary Fig. 4f ). We next analysed data from a label retention assay 48 involving doxycycline-inducible inhibition of H2B-GFP expression in six mice followed by analysis of green fluorescent protein (GFP) retention in progenitor cells collected after 150 days ( Supplementary Fig. 4g ). We found that genes defining the naive HSC gene module were expressed in the label retaining CD150 + CD48 − HSCs and downregulated in cells that lost GFP expression ( Supplementary Fig. 4h ). Together, our data define and validate a unique quiescent transcriptional footprint for the naive HSC state.
Transcriptional bifurcation along the HSC exit from quiescence. Strong antagonistic expression patterns of gene modules are characteristic of lineage bifurcations 49, 50 driven by lineage transcription factors. To examine if such mechanisms are observed in the earliest HSC lineage decisions we stratified cells by their stem-score and studied the build-up of coordinated lineage specific expression in stem cells as they exit the naive state. Pairwise gene correlations in Fig. 1a,b) . Circle size is proportional to tier frequency in the bone marrow. (Fig. 4b,c) . We identified a strong separation between the erythrocyte and myeloid-lymphoid programs 17 , but could not identify groups of cells with early transcriptional separation of myeloid and lymphoid progenitors. For example, Flt3-expressing cells with intermediate stem-scores co-expressed Mpo, Cd52, Sfpi1 (PU.1), Eltd1 and additional myeloid progenitor factors (Fig. 4d,e and Supplementary Fig. 4i ), alongside Dntt, Igh, Satb1 and other genes that are the hallmark of the lymphoid progenitor program. Together, our analysis suggests that transcriptional plasticity is initially retained in naive HSCs, and that low and uncorrelated expression of lineage genes is unlikely to indicate hierarchical fate commitment ( Supplementary Fig. 4j ). Importantly, Vpreb1 expressing B-cell progenitor populations ( Fig. 1) are not Flt3 positive and cannot be linked with the transcriptional variation of lymphoid states found in the core model ( Supplementary Fig. 3h ). Their developmental dynamics in the bone marrow or outside it therefore remains difficult to assess using scRNA-seq data alone. In contrast, the megakaryocyte programs are linked with a core population showing strong stem-ness, supporting their possible very early bifurcation 51 .
Lineage cytokines relax HSC quiescence before triggering differentiation. To perturb in vivo the stem cell differentiation landscapes, we treated mice with Epo and G-CSF ( Supplementary Fig. 5a -c), which are known to induce erythropoiesis and granulocyte production, respectively 50, 52, 53 . Expression of Epor and Csf3r, the receptors for Epo and G-CSF, in tier 3 (Lin − c-Kit + ) untreated cells highlights potentially responsive single-cell populations in the c-Kit populations (Fig. 5a,b) . We profiled 1,582 c-Kit + cells from Epo-treated mice (n = 4) and projected their transcriptional states onto the reference map, colour-coded according to their enrichment relative to controls (Fig. 5c ). This showed an increase of early erythrocyte progenitor clusters (marked by Car1, P ≪ 1 × 10 −5 by Fisher's exact test). Accumulation of these progenitors did not reduce the fraction of myeloid progenitors in the bone marrow, but was correlated with depletion of B-cell progenitors (marked by Vpreb1, P ≪ 1 × 10 −5 ; Fig. 5d and Supplementary Fig. 8d ). Similarly, profiling and mapping to our model of 1,438 c-Kit + cells from G-CSF-treated mice (n = 3) showed an increase in neutrophil signatures (marked by Fcnb; P ≪ 1 × 10
), and depletion of late erythrocyte and B-cell progenitors (P < 0.001), but not of earlier erythrocyte progenitors (Fig. 5e,f and Supplementary Fig. 8d ). Interestingly, we observed increased Ifitm1 expression, typically marking the HSC quiescent state in early erythrocytes or myeloid progenitors following Epo or G-CSF treatments, respectively (Fig. 5g,h 
, Fisher exact test). To study the effects of these stimulations on naive HSC gene programs, we sorted and sequenced additional tier 7 HSCs following both stimulations and mapped these cells to the reference core map (427 Epo and 270 G-CSF cells, Fig. 5i,j) . We found that the expression of the naive HSC signature was consistently reduced in both stimuli, and the overall response to Epo and G-CSF was correlated ( Fig. 5k and Supplementary Fig. 8e ). Importantly, genes implicated with differentiation to either fate were induced in naive HSCs in a cytokineindependent manner. These data support the downregulation of a stem cell quiescent program as preceding the increase of differentiation potential through unspecific activation of haematopoietic lineage gene expression 50 . Activation of downstream differentiation programs can then occur in ligand-receptor positive cells that develop (initially non-specifically) in the relaxed HSC population.
Initiation of neutrophil and monocyte transcriptional programs.
To focus on initiation of the myeloid and lymphoid programs we expanded our cohort of myeloid and lymphoid progenitors with 1,838 additional Lin
, for which we recorded monocyte and DC surface markers described in the literature [54] [55] [56] [57] ( Supplementary Fig. 6a− d) . We then reanalysed the single-cell data depleted in silico from cells specifically expressing markers of B cells, ILC, erythrocytes and basophiles (see Methods) and visualized the resulting meta-cells on the reference map ( Fig. 6a and Supplementary Fig. 6e ). We found a complex network of transcriptional states, making simple hierarchical models difficult to support. Genes associated with lymphoid (Dntt, Flt3, Ly6d), pDC (Siglech, Cd7), cDC (Itgb7, Naaa), monocyte (Csf1r, F13a1) and neutrophil (Elane, Fcnb) fates showed mixed and partially overlapping expression profiles over meta-cells (Fig. 4a) . 2
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Stem-score P roliferation-score Transcription factors (Irf8, Cebpa, Cebpe, Sfpi1 (PU.1) and Satb1) showed similarly complex and overlapping expression profiles (Fig. 6b) . To understand the dynamics of lineage-specific transcriptional programs within such a complex mixture of progenitor states, we scored neutrophil and monocyte transcriptional signatures by pooling the expression of neutrophil-or monocytespecific gene modules (Fig. 6c,d and Supplementary Table 2 ) and visualized these lineage-specific programs over the reference map (Fig. 6e,f) . We could not identify meta-cells with intermediate levels of both monocyte and granulocyte programs ( Supplementary  Fig. 6f ). Importantly, even though our scoring is based on the selection of highly enriched lineage genes alone (for example, Ngp), we observed negatively correlated dynamics in HSC/progenitor genes (Cd34, Gpr56, Eltd1), and transient dynamics for genes associated with early granulocyte differentiation (Elane, Mpo, Gstm1; Fig. 6g ). The transcription factors enriched in the process also showed varied dynamics, with Gfi1 peaking in cells with intermediate activation of the neutrophil program, and Cebpe peaking in the fully mature granulocytes (Fig. 6h) . Similar analysis for the monocyte signature (Fig. 6i ,j) identified a gradual increase in monocyte genes (Fcer1g, F13a1) and allowed for the identification of potential antagonistic transcription factors involved in monocyte and granulocyte differentiation ( Supplementary Fig. 6g ). In summary, our data suggest that quantitative activation of the lineage-specific transcriptional programs for neutrophils and monocytes can be traced in early progenitors, despite their complex structure, and potential plastic differentiation trajectories that characterize their transcriptional space.
Dynamic role of PU.1 in neutrophil and monocyte differentiation.
We used CRISP-seq perturbations to characterize in single cell resolution the regulation of neutrophil and monocyte cell fate differentiation. We collected LSK cells (tier 6, 50,000 cells per recipient mouse) from Cas9-GFP donor mice and infected them with a pool of blue fluorescent protein (BFP)-tagged guide RNA (gRNA) targeting Table 3 ). We then transplanted infected cells into lethally irradiated recipient mice (see Methods). After 9-11 days we performed CRISP-seq analysis on Cas9-GFP + BFP + Lin − c-Kit + cells, measuring both the gRNA and transcriptome in the same single cell 41 ( Fig. 7a) . Projecting the BFP + gRNA infected donor single-cell transcription C a r 1 ( P < < 1 (Fig. 2b) . c, c-Kit + cells (tier 3) were collected from n = 4 mice treated with Epo for 48 h and projected onto the tier 3 model (Fig. 2b and Supplementary Fig. 5 ). Colour coding represents map regions enriched over PBS-injected control. d, Bar plots showing enrichment of lineageannotated groups following Epo treatment compared to PBS-injected control. n = 4 mice. Values represent log 2 fold change between cytokine-and PBStreated mice. Error bars represent 95% confidence intervals. e,f, As in c and d but for n = 3 mice treated with G-CSF for 48 h. g,h, Changes in expression of the stem cell marker Ifitm1 across lineage-annotated populations following Epo (n = 4 mice) (g) and G-CSF (n = 3 mice) (h) treatments. Values represent log 2 fold change between cytokine-and PBS-treated mice. i,j, Projection of HSC (tier 7) following 48 h of Epo (i) and G-CSF (j) treatments onto the core model (Fig. 3b) . k, Differential gene expression between treated and untreated stringent HSCs (as in Fig. 3c ; values represent log 2 fold change) after 48 h Epo (x axis) and G-CSF (y axis) treatments. Inset, Fraction of differentially expressed genes (fold change > 2) in each quartile. n = 1,582 (Epo-treated), n = 1,438 (G-CSF-treated), n = 717 (Epo control) and n = 457 (G-CSF control) single cells. P values represent false discovery rate (FDR)-adjusted two-sided Fisher's exact test. *P < 0.05; **P < 0.001; ***P < 1 × 10
profiles onto the reference map, we reproduced the early progenitors, erythrocyte, neutrophil, basophil, monocyte and B cell states observed in normal haematopoiesis ( Fig. 7b and Supplementary   Fig. 7a-c) . In this relatively early time point of transplantation, we did not detect several populations including pDC and ILC. As transplantation experiments are known to suffer from clonal biases, Table 2) . e,f, Expression of neutrophil (e) and monocyte (f) scores on meta-cells, stratified into four expression levels. g, Single-cell gene expression profiles along the neutrophil differentiation axis. h, Pooled meta-cell expression of key neutrophil genes along the neutrophil differentiation axis. i,j, Gene expression of single cells and meta-cells along the monocyte developmental trajectory, as in g and h.
we expected that single cells sharing a gRNA barcode (gRNA-clone) could represent monoclonal or oligo-clonal populations. We found a significant (P = 0.022, Kolmogorov-Smirnov test) imbalance in the fates of control gRNA-clones towards erythroid and myeloid fates (Fig. 7c , compared to shuffle control in Fig. 7d ; Supplementary  Fig. 7d ), suggesting gRNA-sharing cells are in many cases monoclonal. To experimentally control for this clonal effect, we supported all analysis below using statistical analysis across multiple mice and batches (see Methods).
Of the 12 genes used in our screen (22 gRNA), three genes had a significant effect compared to control gRNA ( Supplementary  Fig. 7e ). Analysing populations of cells with gRNA targeting Cepba and Irf8, we found that Cebpa loss of function leads to the depletion of both monocyte and neutrophil fates and Irf8 depletion strongly affected monocyte, but not neutrophil development (Fig. 7e , marked by Ly86 and Gstm1 expression, respectively). We observed that loss of monocyte potential in Irf8-deficient gRNA-clones also correlated with increase in the Gstm1-marked neutrophils ( Supplementary Fig. 7f ), suggesting that loss of Irf8 and blocked monocyte differentiation may result in compensatory activation of genes linked with other fates.
According to consensus myeloid differentiation models, PU.1 is the master regulator of all myeloid lineages 58 . Surprisingly, PU.1 knockout (KO) in Lin − c-Kit + Sca-1 + (LSK) haematopoietic progenitors resulted in the accumulation of neutrophil progenitors in the bone marrow ( Supplementary Fig. 8a ). To further examine this effect in a setting not affected by competition with other gRNA, we infected LSK cells separately with either PU.1 gRNA labelled with mCherry, or control gRNA labelled with BFP, and transplanted a mix of equal numbers of PU.1 KO and control donor cells into four recipient mice. After 11 days, cells were analysed by flow cytometry, showing that donor cells were highly enriched for PU.1 gRNA infected cells, compared to control gRNA (10.6-fold; P < 0.05 by two-tailed, paired Student's t-test, Fig. 8a) . However, PU.1 KO cells failed to generate Ly6G + CD11b + neutrophils, containing instead a large population of Ly6G + CD11b − cells, not found in the control gRNA or homeostatic bone marrow 59, 60 (Fig. 8b,c and Supplementary  Fig. 8b ). MARS-seq analysis of cells from the same mice, sorted for Lin − c-Kit + and Ly6G + gates, revealed marked differences between PU.1 KO cells and control ( Fig. 8d and Supplementary Fig. 8c ). These included higher expression of genes critical for neutrophil differentiation and function (Mmp8, Itgam, Il1b and Ccl6; Fig. 8e ). To better understand the effect of the knockout on neutrophil differentiation, we projected PU.1 KO and control meta-cells onto our derived neutrophil differentiation signature (stage I; Fig. 6c ), and on a mature neutrophil signature defined by genes upregulated in the most differentiated neutrophil population (stage II; Supplementary Fig. 8d ). This showed that the initial increase in neutrophil differentiation is independent of PU.1, but further neutrophil maturation and activation of stage II genes is completely blocked in PU.1 KO (Fig. 8f) . 
Frequency in gRNA-clone Supplementary Fig. 7a ,b, mix 1 and mix 2 in Supplementary Table 3 ) onto the haematopoietic model (Fig. 2b). c,d , Imbalance of the cellular output in CRISP-Seq experiments (c) compared to the expected distribution from a shuffled matrix (d). Each column represents the lineage output of all cells sharing a unique control gRNA combination (gRNA-clone) in a single recipient mouse. n = 27 clones over 17 independent animals. P = 0.02, two-sided Kolmogorov-Smirnov test. e, Frequencies of selected lineages (marked by Car1, Ly86 or Gstm1 as in Fig. 1 ) in n = 31 Cebpa, n = 25 Irf8 or n = 50 control gRNA-clones. P values represent FDR-adjusted two-sided Mann-Whitney test.
To validate that this effect is intrinsic to PU.1 and not due to systemic effects, we infected LSK cells with the same constructs and cultured the progenitors ex vivo in monocyte (GM-CSF) and granulocyte (G-CSF) differentiation media. Similar to the in vivo experiment, MARS-seq analysis revealed that PU.1 KO cells produced neutrophil progenitors arrested in stage I (Fig. 6g and Supplementary Fig. 8e ). However, the proliferation of these cells was markedly different in the G-CSF versus GM-CSF supplemented media: G-CSF, but not GM-CSF triggered a large expansion of the PU.1 KO neutrophil progenitors (Supplementary Fig. 8f ). Importantly, GM-CSF could initiate the monocyte differentiation program in PU.1 KO cells ex vivo, showing that the in vivo absence of monocytes is not intrinsically dependent on PU.1 function ( Supplementary Fig. 8g,h ). Taken together, our analysis shows that initial differentiation into the granulocyte and monocyte lineages is not dependent on PU.1. The aberrant CD11b − Ly6G + neutrophil observed in PU.1 KOs exhibits morphological segmentation, but failed to express several mature neutrophil genes, including genes related to secondary and tertiary granule formation 61, 62 ( Fig. 8h and Supplementary Fig. 8i ).
Discussion
Multiple lines of evidence support the hypotheses that bone marrow differentiation is by far less hierarchical and canalized in the Waddington sense than previously assumed. Although HSCs are suggested to occupy specific niches in the bone marrow 63, 64 , their downstream differentiation dynamics from the ground state have so far been linked only to dynamic and complex microenvironments 65 , which serve as transient organizational units as cells migrate from the bone marrow and further differentiate into other tissues. This implies that haematopoietic progenitors are typically not protected from receiving multiple signals early in their differentiation, including various inflammatory and other immune/metabolic signals, and open the way for incomplete cell lineage sorting as a natural part of their dynamics 66, 67 . Because haematopoiesis is highly dynamic and adaptive, avoiding tightly regulated and irreversibly committed progenitor subpopulations and maintaining differentiation flexibility may increase the system responsiveness, as supported here by the distribution of progenitor states following cytokine stimulation. Moreover, even as stem cells acquire a neutrophil, lymphocyte or erythrocyte progenitor state in the bone marrow, their plasticity is maintained and full commitment often established in other tissues (for example, thymus, spleen, blood) after migration 68 . Although the concept of plastic and network-like haematopoietic differentiation is far from new, the high-resolution prism facilitated by scRNA-seq provides a detailed substitute for the traditional coarse-grain tree models of haematopoietic differentiation. The model we introduce here is initiated from transcriptional states and their potential similarities, but the inference of dynamics on it must be taken with caution and can only be fully resolved by adding the dimension of time (for example, pulse chase), sophisticated lineage tracing, epigenomics and additional functional perturbations 10, 51, 69 . Nevertheless, the map we outline represents a reference haematopoietic differentiation model with resolution and reproducibility that facilitate the integration of all these additional layers of information and dynamics. We show that gene regulation continuously repurposes genes across lineages and fates, bringing single cells from different lineages closer in transcriptional space and potentially skewing models for differentiation dynamics. By anchoring models on functionally characterized ground states (CD150 + LT-HSC in our case), and by combining scRNA with stimulations (cytokines) and perturbations (CRISP-seq), we can highlight potential differentiation trajectories in the model and examine the regulatory mechanisms controlling them. The remarkable reproducibility of the inferred transcriptional states (between mice, in vivo as well as ex vivo stimulations and genetic perturbation) confirms that the scRNA-based model of haematopoiesis is becoming the ideal reference for future quantitative and functional analysis of the system, both in normal and disease states.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-018-0121-4.
Mouse strains. MARS-seq was performed on six-to eight-week-old female C57BL/6 mice. For cytokine-mediated in vivo challenge of native adult haematopoiesis, seven-week-old mice (~15 g) were injected intraperitoneally (i.p.) with 150 IU human Epo (Recormon/Epoitin beta; in 200 µ l PBS; n = 4, 3 independent experiments) or subcutaneously (s.c.) with 4.8 µ g human G-CSF (Neupogen; in 100 µ l PBS; n = 3, 2 independent experiments) over two consecutive days and killed on the third day together with their respective i.p. and s.c. injected PBS controls. Cas9-GFP mice were purchased from The Jackson Laboratory and backcrossed with C57BL/6 mice to produce homozygotes 41 . Animal studies were performed without randomization or blinding.
Ethical compliance. All animals were housed according to guidelines at the Weizmann Institute of Science and the German Cancer Research Center. All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC), application no. 24120116-3. This work complies with all relevant ethical regulations pertaining to animal experiments.
Isolation of haematopoietic progenitors from bone marrow. Bone marrow was isolated from mouse tibiae, femora and ilia leg bones by crushing in MACS buffer (PBS supplemented with 2 mM EDTA and 0.5% BSA) and filtered through a 70 μ m cell strainer. Omitting enrichment, single-cell suspensions were stained for 30 min on ice with fluorophore-conjugated antibodies, filtered through a 40 μ m cell strainer and FACS-sorted with a FACSAria Fusion cell sorter (BD Biosciences) according to the sorting strategies listed in Supplementary Fig. 1b . Antibody clones and quantities (six hindleg bones per mouse were stained in 100 μ l MACS buffer) used for single-cell sorting are specified in Supplementary Table 4 .
CRISPR loss-of-function screening. gRNA oligos were ordered from iDT and cloned into a guide RNA lentiviral vector plasmid as previously described 41 . Briefly, pairs of oligonucleotides with BsmBI-compatible overhangs were phosphorylated with T4 polynucleotide kinase (NEB) and annealed. The fragments were then ligated into a pool of purified BsmBI-digested CRISP-seq plasmids (BFP backbone #85707, mCherry backbone #85708, Addgene) that contained a unique gRNA identifier 41 (UGI). Ligated constructs were transformed into competent bacteria and single clones were picked and propagated. Presence of a gRNA and unique UGI was verified by Sanger sequencing. CRISP-seq-UGI lentiviral particles were produced by transfection of 293T cells (jetPEI transfection reagent, Polyplus) followed by concentration in Amicon 100 kDa 15 ml columns (Millipore), as described previously 41 . For the in vivo CRISP-seq assay, bone marrow from Cas9-GFP donor mice was enriched for c-Kit (CD117) using magnetic cell separation (MACS, Miltenyi Biotec) and FACS-sorted for GFP + Lin − c-Kit + Sca-1 + bone marrow progenitors. Donor progenitors were infected with various combinations of lentiviral gRNAs (Supplementary Table 3 ) in StemSpan Serum-Free Expansion medium (SFEM, StemCell Technologies) supplemented with 1% penicillin/streptavidin, 2 μ g ml −1 polybrene, Flt3, Il-3, Tpo and stem cell factor (SCF) (all at 10 ng ml
from Peprotech) for 18 h on a non-tissue culture treated 96-well plate 41 . Note that for the stringent PU.1 experiment, half the cells were infected with BFP + control guides and the other half with PU.1-mCherry (mixes 3 and 4 in Supplementary Table 3); both were combined before transplantation. Nine-week-old female C57BL/6 recipient mice were lethally irradiated (950 cGy) 18 h before retro-orbital injection of 50,000 PBS-washed infected donor cells and 200,000 recipient isogenic flushed whole bone marrow carrier cells. Drinking water was supplemented with 200 mg ml −1 ciprofloxacin. For the ex vivo CRISP-seq assay, Cas9-GFP + LSK cells were infected with PU.1-mCherry and BFP + control guides as described above. 10,000 PU.1-mCherry and 10,000 control-BFP infected cells were cultured together for 5 days in StemSpan supplemented with 10% FBS, 1% penicillin/streptavidin, SCF, Tpo and either murine GM-CSF (all at 10 ng ml −1 from PeproTech) or 10 ng ml −1 human recombinant G-CSF (Neupogen, Filgrastim) on non-tissue culture treated 24-well plates. Medium was topped up on day 4. On day 6, StemSpan was replaced with Iscove's Base Medium (Biological Industries, Israel) while retaining all supplements listed above, and cells were re-seeded onto 24-well plates. On day 9, 50% of the cells were taken for FACS, and the remainder were seeded on 12-well plates. After another medium top-up on day 12, cells were analysed by flow cytometry on day 14.
Giemsa staining. For May-Gruenewald Giemsa (MGG) staining, cells were FACSsorted into MACS buffer and concentrated in microscope slides by cytospin. Slides were air-dried and fixed in methanol for 5 min for long-term storage. Fixed and dried slides were stained for 5 min in May-Gruenewald solution (Sigma), rinsed briefly with PBS and stained with Giemsa (Sigma) for 40 min. Stained slides were rinsed under running tap water and air-dried for 10 min. Images were obtained under a microscope with a × 100 objective, using immersion oil.
Single-cell index sorting. Isolated cells were single-cell-sorted into 384-well cell capture plates containing 2 µ l of lysis solution and barcoded poly(T) reversetranscription (RT) primers 24 for scRNA-seq. Barcoded single-cell capture plates were prepared with a Bravo automated liquid handling platform (Agilent) as described previously 24 . To record marker levels of each single cell, the FACS Diva 7 'index sorting' function was activated. During index sorting, the intensities of all FACS markers were recorded and linked to each cell's position within the 384-well plate 20 . Four empty wells were kept in each 384-well plate as a no-cell control during data analysis. Immediately after sorting, each plate was spun down to ensure cell immersion into the lysis solution, snap frozen on dry ice and stored at − 80 °C until processed.
RNA-seq library preparation. Single-cell transcriptome libraries were prepared as previously described 24 . Briefly, mRNA from cells sorted into MARS-seq capture plates was barcoded and converted into cDNA and pooled using an automated pipeline. The pooled sample was then linearly amplified by T7 in vitro transcription and the resulting aRNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina adapter sequences during ligation, followed by reverse transcription and PCR. For CRISP-seq, 12% of the in vitro transcription material was used for UGI-library preparation as described previously 41 . Briefly, fragmentation was omitted, the aRNA ligated to a common sequence that was used as a primer dock for reverse transcription, and a pool barcode and Illumina adapter sequences introduced during a two-step PCR to complete UGI-seq libraries. Library quality and concentration were assessed as described in ref. 24 . All MARS-seq/UGI-seq libraries were sequenced using an Illumina NextSeq 500 at a median sequencing depth of 46 
Mapping cells to an existing MetaCell model.
Given an existing reference single-cell data set and meta-cell model, and a new set of single-cell profiles, we extracted for each new cell the K ref reference cells with top Pearson correlation over the normalized gene features defined for the reference model, as described in Supplementary Note 1. The distribution of cluster memberships over these K-neighbours was used to associate the new cell with a reference meta-cell (by majority voting) or to project the cell in 2D by weighted average of the linked reference clusters' mapped x and y coordinates. In the applications here we set K ref to 50 .
Filtering and clustering tier 3 cells. A total of 105 amplification batches of tier 3 cells (Supplementary Fig. 1c) were collected. Cells with UMI count < 500 and genes with UMI count < 10 were discarded, resulting in 12,051 cells (Supplementary Table 1 ). MetaCell gene selection identified 376 markers (excluding ribosomal and cell cycle genes from Supplementary Table 2 ). Graph coverage was performed using K range = 150 and N min = 20. Visualization of tier 3 was performed with T edge = 0.05 and graph maximum degree set to 8. Meta-cells were annotated with specific differentiation fates if the geometric mean of UMIs for one of the 15 established lineage markers was fourfold (or tenfold higher for the neutrophil Ltf) higher than the median meta-cell geometric mean.
Defining and clustering the core data set. To sensitively filter out cells that are significantly committed toward a differentiation fate and focus on more early progenitor cells, we first identified sets of genes G fate that are significantly overexpressed in each of the fates identified in tier 3. This was done by analysis of pooled expression in the groups of tier 3 clusters that were associated with specific lineages using marker genes as described above, and identification of genes with at least 50 UMIs and at least twofold enrichment in this pool over the background. For each G fate , we analysed the distribution of e(G fate ,c) over all cells and determined thresholds for filtering for each lineage separately (Supplementary Fig. 4a ). This resulted in filtering 7,075 cells and retaining 9,348 cells for further analysis. Clustering was performed using MetaCell analysis (but excluding specifically the strong neutrophil differentiation module, including Camp, Ltf, S100a8, S100a9 and the haemoglobin genes Hba-a2, Hbb-b1 and Beta-s), using bootstrap to derive robust clustering (resampling 70% of the cells in each iteration, and clustering the co-cluster matrix with minimal cluster size set to 20, and number of bootstrap clusters set to 50).
Proliferation-score. The proliferation-score for each cell c was defined as f(G prolif ,c) where G prolif includes the cell cycle gene module identified as described above (Supplementary Table 2 ).
Stem-score. Genes with statistically significant correlation with Hlf expression in a UMI matrix downsampled to 800 UMIs per cell (FDR-adjusted P < 1 × 10 −3 ; Fisher's exact test) were used to defined the set G stem (Supplementary Table 2 ). The stem-score was defined for each cell as f(G stem ,c) (see section 'UMI transformation and gene module score') using log-transformed expanded values to maximize information extracted from genes with low expression mean.
Correlations within the core data set. Cells within the core data set were stratified by their stem-score (III, 95-100%; II, 80-95%; I, 60-80% percentiles). Spearman correlations were calculated within each percentile on the log-transformed UMI matrix downsampled to 1,200 UMIs per cell. Only genes negatively correlated with the stem-score are shown in Fig. 4a-c . Supplementary Fig. 4j shows Pearson correlations over the log geometric mean of UMI in each cluster.
Defining and clustering the myeloid progenitor data set. The myeloid progenitor data set was extracted from cells from tiers 3, 4 and 5 similarly to the creation of the core data set. Cells were filtered for high expression of gene sets G fate of the following excluded lineages: ILC (Ccl5), megakaryocytes (Pf4), erythrocytes (Car1 and Hba-a2), basophils (Prss34) and eosinophils (Prg2), and B cells (Vpreb1). This resulted in filtering 4,886 cells and retaining 11,960 cells for further analysis. The myeloid data set was analysed by MetaCell with bootstrap (resampling rate = 70%, minimal cluster size set to 20, and K = 60). Clusters featuring high mean levels of excluded lineage genes were also removed from the data set (Prss34, Prg2, Mcpt8, Vpreb1, Vpreb3, Car1, Mt2, Klf1, Ccl5, Pf4, Apoe and Cd79b), providing additional filtering and retaining for analysis a total of 36 clusters and 8,395 cells. 2D visualization was performed as described in the section 'Mapping cells to an existing Metacell model' .
Neutrophil and monocyte differentiation gradients. To define the neutrophil differentiation program we identified clusters of the myeloid map exhibiting high expression of neutrophil genes (16-fold enrichment of Camp compared to the median expression across clusters). We extracted a set of genes G neut differentially expressed in these cells compared to the rest of the myeloid data set (χ 2 test; P < 1 × 10 −9 with fourfold or higher change, Supplementary Table 2) . We computed the neutrophil signature across clusters as the share of G neut expression from the total UMIs in each cluster.
Monocyte signature was defined similarly, comparing between high monocyte clusters (two-and twofold enrichment of Csf1r and Ly86). We extracted a set of genes G mon differentially expressed in monocytes compared to the rest of the myeloid data set (χ 2 test; P < 1 × 10 −9 with twofold or higher change, Supplementary Table 2) . CRISP-seq low-level processing. Sequenced reads containing the UGI-seq 5′ primer (TCCCCGCGTCGACGGATCC) with up to 2 bp mismatches were extracted for further UGI-seq processing. We first extract plate barcode, cellspecific barcode (7 bp), random molecular tags (RMTs, 8 bp) and unique guide identifier (UGI, 8 bp) for each read. Reads with low quality (Phred < 27) or without a valid UGI sequence (up to 1 bp mismatch), cell barcode (up to 1 bp mismatch) or plate barcode (exact match) were discarded. Triplets with fewer than 30 reads were discarded as errors, and each cell received a vector of UGI molecule counts. To assign a binary label per cell, we consider UGI molecules > 1 as positive cells.
Clonal analysis of CRISP-seq experiments. All the Cas9 + BFP + donor-derived cells in the CRISP-seq experiment come from a pool of cells infected with a small set of unique gRNA. Hence, the cellular output on days 9-11 in each mouse may derive from one or more founder cells infected with the same combination of gRNA. Consequently, it is not possible to deduce the exact clonal composition of donor-derived cells. However, if we set a lower bound on the number of founder cells by pooling together all cells sharing the same gRNA combination in a single recipient mouse (which we term 'gRNA-clone'), we find a significant variance in the erythroid contribution for each gRNA-clone (Fig. 7c,d and Supplementary  Fig. 7d ). We note that this effect stands even when considering gRNA-clones containing control gRNA only.
We surmise that there is a strong clonal effect on cellular output in our transplantation assay (probably due to a strong selective pressure), which may obscure the real quantitative phenotype when inactivating a specific transcription factor. To overcome clonality, we turned to assessing cellular output at the gRNAclone level instead of the single cell level (Fig. 7e) . We calculated P values using FDR-adjusted Mann-Whitney tests on all gRNA with more than 500 singly infected cells, testing enrichment for erythrocytes (Car1 and Hba-a2), monocytes (Ly86), neutrophils (Gstm1 and Fcnb) or B cells (Vpreb1) (Supplementary Fig. 7e ).
Analysis of in vivo and ex vivo PU.1 KO experiment. We pooled PU.1 and control infected cells from Lin − c-Kit + and Ly6G + sorting gates and used MetaCell to analyse 6,529 single cells. To position meta-cell on the neutrophil differentiation gradient, we used the neutrophil program defined in Fig. 6 (stage I), as well as an additional set of genes (stage II, Supplementary Fig. 8d and Supplementary Table 2 ) expressed in Ly6G + control cells, but not in the myeloid data set. To define these genes, we identified clusters of the myeloid map exhibiting fourfold enrichment of Ccl6, and chose all genes differentially expressed in these cells compared to the rest of the data set (χ 2 test; P < 1 × 10 −9 with 2.8-fold or higher change).
Statistics and reproducibility. All biological and technical replicates in the study are documented in Supplementary Fig. 1c and Supplementary Table 1 , which state the number of mice (including identities), batches and cells. All experiments were performed at least three times, except for the Giemsa staining, which was performed twice, and the ex vivo PU.1 KO, which was performed once. All replication attempts were successful. No statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to animal allocation during experiments and outcome assessment.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Code availability. Scripts and auxiliary data needed to reconstruct analysis files from count matrices to full figures are available in a git repository: https:// bitbucket.org/tanaylab/hematopoiesis2018.
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Sample size
We chose to sequence and analyze 12051 tier 3 cells so that 0.019%-0.122% of the whole bone marrow is captured by each meta-cell. This allows an extensive coverage of all distinct transcriptional profiles and conforms to the gold standard in the field. Full description of sample sizes is detailed in Supplementary Fig. 1 . No statistical tool was used to apriori choose sample size.
Data exclusions Exclusion of single cells was done according to detection depth (less than 500 UMI per cell). Exclusion criteria for specific analyses is described in the Methods section, paragraphs: 'Filtering and clustering tier 3 cells', 'Defining and clustering the core dataset', 'Defining and clustering the myeloid progenitor dataset'
Replication
Single cells were collected form a total of 47 independent mice. For tier 3 analysis (Figure 1 ), cells were collected from 5 different mice, at least on four independent sorting sessions. All replication attempts were successful. CRISP-Seq samples were collected from 17 independent mice, on two independent experiments.
Randomization No randomization was done, since all animals used were isogenic mice.
Blinding
No blinding was done, since the computational framework was identical for all processed animal samples.
Reporting for specific materials, systems and methods A list of all antibodies used in this study can be found in Supplementary Table 4 Validation
For each experiment, each FACS antibody was compared (separately) to an unstained sample. Only FACS antibodies that yielded
